Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 38 of the 43 references it cites were found in a registry or an index; 41 of the 58 sources its claims cite were checked for support.

Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men

Open access
Kerksick, Chad M. · 2024 · Nutrients

Abstract

Background: Choline is an essential nutrient required for proper cell functioning. Due to its status as a precursor to acetylcholine, an important neurotransmitter connected to cognition and neuromuscular function, maintaining or enhancing choline levels is of interest. Supplementation with alpha-glycerylphosphorycholine (A-GPC) can maintain choline levels, but its ability to offer support towards cognition remains an area of ongoing research. Methods: Using a randomized, double-blind, placebo-controlled, crossover approach, 20 resistance-trained males (31.3 ± 11.0 years, 178.6 ± 7.3 cm, 84.6 ± 11.4 kg, 15.4 ± 5.6% body fat) consumed either a placebo (PL), 630 mg A-GPC (HD), or 315 mg (LD) A-GPC (GeniusPure®, NNB Nutrition, Nanjing, China). After resting hemodynamic assessments, participants took their assigned dose and had cognitive assessments (Stroop, N-Back, and Flanker), visual analog scales, and hemodynamics evaluated 60 min after ingestion. All participants then warmed up and completed vertical jumps and bench press throws before completing a bout of lower-body resistance exercise (6 × 10 repetitions using the Smith squat at a load of 70% 1RM). Venous blood was collected 5, 15, 30, and 60 min after completion of the squat protocol to evaluate changes in growth hormones, and follow-up visual analog scales and cognitive measurements were evaluated 30 min after completing the exercise bout. Results: When compared to PL, changes in Stroop total score were statistically greater after HD (13.0 ± 8.2 vs. 5.2 ± 9.0, p = 0.013, d = 0.61) and LD (10.8 ± 7.7 vs. 5.2 ± 9.0, p = 0.046, d = 0.48) administration, in addition to significantly faster times to complete the Stroop test in the HD group when compared to PL (−0.12 ± 0.09 s vs. −0.05 ± 0.09 s, p = 0.021, d = 0.56). No significant differences between groups were found for the Flanker and N-Back assessments, while a tendency was observed for HD to have faster reaction times when compared to PL during the Flanker test. No group differences were realized for visual analog scales, physical performance, or growth hormone. Statistically significant changes in heart rate and blood pressure were observed in all groups, with all recorded values aligning with clinically accepted normative values. Conclusions: HD and LD A-GPC supplementation significantly increased cognitive performance in a group of young, healthy males as measured by changes in the Stroop Total Score and completion time of the Stroop test. These results offer unique insight into the potential for A-GPC to acutely increase cognition in a group of young, healthy males. While previous research has indicated potential for A-GPC to acutely improve cognition in clinical populations, extending these outcomes to healthy individuals can be potentially meaningful for a wide variety of populations such as athletes, race car drivers, military operators, and other non-athletic populations who desire and have a need to improve their mental performance. This study was retrospectively registered as NCT06690619 on clinicaltrials.gov.

Overview

CoChat Summary

TL;DR

In a randomized, double-blind, placebo-controlled crossover trial, acute alpha-glycerylphosphorylcholine (A-GPC) supplementation improved some Stroop cognitive performance measures in healthy resistance-trained men. Higher-dose A-GPC (630 mg) also produced faster Flanker compatible reaction times, but no significant effects were found for visual analog scales, most physical performance outcomes, or growth hormone.

Key findings

  • Stroop total score change was significantly greater after high-dose A-GPC (13.0 ± 8.2) and low-dose A-GPC (10.8 ± 7.7) versus placebo (5.2 ± 9.0); HD vs PL p = 0.013, d = 0.61; LD vs PL p = 0.046, d = 0.48.
  • Stroop time per score improved significantly with HD versus PL (−0.12 ± 0.09 s vs. −0.05 ± 0.09 s, p = 0.021, d = 0.56), with a trend for LD versus PL (−0.10 ± 0.08 s, p = 0.072, d = 0.42).
  • Flanker compatible reaction time was significantly faster with HD versus PL (−51.2 ± 53.9 ms vs. −13.0 ± 51.6 ms, p = 0.018, d = 0.58); no significant differences were found for most Flanker and N-Back outcomes.
  • No group differences were realized for visual analog scales, physical performance, or growth hormone; growth hormone AUC was HD 380 ± 279, LD 414 ± 273, PL 351 ± 272 ng/mL/min, p = 0.438.

Methods

  • Randomized, double-blind, placebo-controlled, 3-way crossover study in 20 resistance-trained males (31.3 ± 11.0 years, 178.6 ± 7.3 cm, 84.6 ± 11.4 kg, 15.4 ± 5.6% body fat) who consumed placebo, 315 mg A-GPC (LD), or 630 mg A-GPC (HD).
  • Cognitive assessments (Stroop, N-Back, Flanker), visual analog scales, and hemodynamics were evaluated 60 min after ingestion and again 30 min after a lower-body resistance exercise bout (6 × 10 Smith squats at 70% 1RM); venous blood was collected 5, 15, 30, and 60 min post-exercise for growth hormone.
  • Main analyses used one-way repeated-measures ANOVA for upper/lower body performance, VAS, GH AUC, and cognitive change scores; mixed factorial ANOVAs for vital signs and growth hormone; LSD post hoc comparisons; Cohen’s d; significance set at p ≤ 0.05 and trend at p > 0.05 to ≤ 0.10.

Limitations

  • The paper states that only males were recruited, so findings are limited to healthy, physically active males who were not competitively active; more research involving females and other populations is needed.
  • The paper states that only a single dose was delivered, so effects of longer supplementation regimens remain unknown.
  • The paper states that a full discovery of pairwise comparisons using LSD was completed and that more rigorous correction for pairwise comparisons may have impacted final outcomes; it also states that no a priori sample size calculation was completed.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/nu16234240

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Timeline schematic of study design and procedures.
Figure 1 Timeline schematic of study design and procedures.CC BY · PubMed Central
Figure 2 Consolidated Standards of Reporting Trials (CONSORT) diagram.
Figure 2 Consolidated Standards of Reporting Trials (CONSORT) diagram.CC BY · PubMed Central
Figure 3 Delta Stroop total score. * = Different than PL (p < 0.05).
Figure 3 Delta Stroop total score. * = Different than PL (p < 0.05).CC BY · PubMed Central
Figure 4 Delta time per score. * = Different than PL (p < 0.05).
Figure 4 Delta time per score. * = Different than PL (p < 0.05).CC BY · PubMed Central

Verification

Claims the paper makes

26 Valid · 5 Not valid · 7 Not checked · 64 Own results and interpretations

35 more claims · 6 with their cited sources checked

Create a free account to see all 102 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 20
  • Probably not a substantial claim. 54

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 43 references

Cited by

See all 8

Metadata

Authors
Kerksick, C. M.
Affiliations
Lindenwood University (US)
Corresponding author
Kerksick, Chad M.
Venue
Nutrients
Publisher
MDPI AG
Published
2024-12-09
Volume
16
Issue
23
Pages
4240
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4405191041
Cited by
8
References
43
Citations by year
2026: 6 · 2025: 2
FWCI
1.27
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • Preprints.org (submittedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Nanjing Nutrabuilding Bio-tech Co., Ltd. (NNB Nutrition, Nanjing, China) through a restricted grant to The Center for Applied Health Sciences
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
  • Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
  • Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
Keywords
choline supplementation, cognitive performance, resistance training, acute supplementation, Stroop task, flanker task, n-back task, growth hormone, hemodynamics, acetylcholine precursor, healthy men, resistance-trained men, squatting, neuromuscular function, blood pressure response, heart rate response
MeSH terms
Adult, Cognition, Double-Blind Method, Glycerylphosphorylcholine, Humans, Male, Cross-Over Studies, Dietary Supplements, Resistance Training, Young Adult, Healthy Volunteers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men. https://app.cochat.ai/papers/10.3390/nu16234240
The paper
Kerksick, C. M. (2024). Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men. Nutrients. https://doi.org/10.3390/nu16234240

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.